{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:21:33Z","timestamp":1768882893806,"version":"3.49.0"},"reference-count":0,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,10,2]],"date-time":"2003-10-02T00:00:00Z","timestamp":1065052800000},"content-version":"vor","delay-in-days":2192,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Quadruple therapy (bismuth, metronidazole and tetracycline (BMT)\u2003+\u2003proton pump inhibitor) is touted as being\u2003&gt;95% effective, regardless of metronidazole resistance. We tested a 10\u2010day b.d. quadruple therapy for treatment of <jats:italic>H. pylori<\/jats:italic> infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Anti\u2010<jats:italic>H. pylori<\/jats:italic> therapy consisted of lansoprazole 15\u2003mg b.d. plus tetracycline 500\u2003mg b.d., metronidazole 500\u2003mg b.d., and swallowable Pepto\u2010Bismol caplets (2 b.d.) for 10 days. <jats:italic>H. pylori<\/jats:italic> status was evaluated by culture and histology before and 4 or more weeks after therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The cure rate for intention\u2010to\u2010treat was 70%. Treatment success was calculated overall and separately in relation to antimicrobial resistance patterns. The cure rate among the metronidazole\u2010sensitive isolates was 89.7% (26 of 29) vs. 41.2% (7 of 17) of the metronidazole\u2010resistant isolates (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.005). Moderate (<jats:italic>n<\/jats:italic>\u2003=\u20031) or severe (<jats:italic>n<\/jats:italic>\u2003=\u20033) side\u2010effects were experienced in four patients with only one withdrawing because of side\u2010effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Twice a day quadruple therapy is effective for metronidazole\u2010sensitive strains but its usefulness is markedly reduced by the presence of pre\u2010treatment metronidazole resistance. Twice a day quadruple therapy can be recommended in locations where background metronidazole resistance is uncommon. Possibly, 14\u2010day therapy or a higher dosage of metronidazole provide better results with metronidazole\u2010resistant <jats:italic>H. pylori<\/jats:italic>.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1997.00219.x","type":"journal-article","created":{"date-parts":[[2003,10,15]],"date-time":"2003-10-15T03:02:49Z","timestamp":1066186969000},"page":"935-938","source":"Crossref","is-referenced-by-count":47,"title":["Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of <i>Helicobacter pylori<\/i> infection"],"prefix":"10.1111","volume":"11","author":[{"given":"D. Y.","family":"GRAHAM","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"HOFFMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. M. T.","family":"EL\u2010ZIMAITY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. P.","family":"GRAHAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"OSATO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,2]]},"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1997.00219.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1997.00219.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1997.00219.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T08:00:35Z","timestamp":1693296035000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1997.00219.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1046\/j.1365-2036.1997.00219.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1997.00219.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}